Axonal Degeneration as a Predictor of Outcome in Neurological Disorders

Axonal Degeneration as a Predictor of Outcome in Neurological Disorders

This chapter reviews the role of axon degeneration as a predictor of clinical outcome in a spectrum of neurological disorders. This chapter begins with methods to asses damaged axons. This includes amyloid precursor protein Immunocytochemistry and cerebrospinal fluid "Surrogates." Axonal d...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Medana, I, DeLuca, G, Esiri, M
Format:	Book section
Veröffentlicht:	Elsevier 2005

Ähnliche Einträge

Axonal damage: a key predictor of outcome in human CNS diseases.
von: Medana, I, et al.
Veröffentlicht: (2003)

Axonal damage: a key predictor of outcome in human CNS diseases.
von: Medana, I, et al.
Veröffentlicht: (2003)

Evidence of axonal damage in human acute demyelinating diseases.
von: Ghosh, N, et al.
Veröffentlicht: (2004)

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.
von: DeLuca, G, et al.
Veröffentlicht: (2004)

The contribution of demyelination to axonal loss in multiple sclerosis
von: DeLuca, G, et al.
Veröffentlicht: (2006)

The contribution of demyelination to axonal loss in multiple sclerosis.
von: DeLuca, G, et al.
Veröffentlicht: (2006)

Protein co-expression with axonal injury in multiple sclerosis plaques.
von: Diaz-Sanchez, M, et al.
Veröffentlicht: (2006)

Axons Degenerate in the Absence of Mitochondria in C. elegans
von: Rawson, Randi L., et al.
Veröffentlicht: (2015)

The extent of axonal loss in the long tracts in hereditary spastic paraplegia.
von: Deluca, G, et al.
Veröffentlicht: (2004)

Axonal injury in cerebral malaria.
von: Medana, I, et al.
Veröffentlicht: (2002)

The outcome of depressive disorders in neurology patients: a prospective cohort study.
von: Carson, A, et al.
Veröffentlicht: (2003)

The outcome of depressive disorders in neurology patients: A prospective cohort study
von: Carson, A, et al.
Veröffentlicht: (2003)

Neurologic symptoms and diagnosis in adults with mast cell disease.
von: Smith, J, et al.
Veröffentlicht: (2011)

Evidence-based neurology : management of neurological disorders /
von: Candelise, Livia
Veröffentlicht: (2007)

Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria.
von: Medana, I, et al.
Veröffentlicht: (2007)

The epidemiology of neurological disorders /
von: Martyn, Christopher, et al.
Veröffentlicht: (1998)

Different rates of axonal degeneration in the crossed and uncrossed retinofugal pathways of Monodelphis domestica.
von: Guillery, R, et al.
Veröffentlicht: (1993)

Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions.
von: Heffernan, C, et al.
Veröffentlicht: (2005)

Child neurology practice and neurological disorders in East Africa.
von: Idro, R, et al.
Veröffentlicht: (2010)

Approach to the patient with neurologic disease
von: De Luca, G, et al.
Veröffentlicht: (2011)

Out with the old, in with the new: Could plasma exchange be used to fill a therapeutic gap in neurology?
von: Spencer, JI, et al.
Veröffentlicht: (2021)

Treatment of attention deficits in neurological disorders.
von: Coulthard, E, et al.
Veröffentlicht: (2006)

Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
von: Friese, M, et al.
Veröffentlicht: (2007)

Antibodies associated with paraneoplastic neurological disorders.
von: Vincent, A
Veröffentlicht: (2005)

Sleep problems in children with neurological disorders.
von: Dorris, L, et al.
Veröffentlicht: (2008)

Global burden of pediatric neurological disorders
von: Newton, C
Veröffentlicht: (2018)

Autoimmune channelopathies and related neurological disorders.
von: Vincent, A, et al.
Veröffentlicht: (2006)

Defining causality in COVID-19 and neurological disorders
von: Ellul, M, et al.
Veröffentlicht: (2020)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
von: Coles, A, et al.
Veröffentlicht: (2003)

Wrangling RNA: Antisense oligonucleotides for neurological disorders
von: Talbot, K, et al.
Veröffentlicht: (2019)

Spinal cord lesions play only a limited role in determining the degree of cord atrophy in multiple sclerosis
von: Evangelou, N, et al.
Veröffentlicht: (2003)

Study protocol: Early neurological deterioration in patients with minor stroke, frequency, predictors, and outcomes in Vietnam single-centre study
von: Nguyen, DT, et al.
Veröffentlicht: (2024)

Axonal loss in the optic nerve and tract in multiple sclerosis
von: Esiri, M, et al.
Veröffentlicht: (2000)

Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barré syndrome mouse model
von: McGonigal, R, et al.
Veröffentlicht: (2022)

Pathogenic autoantibodies to neuronal proteins in neurological disorders.
von: Vincent, A, et al.
Veröffentlicht: (1999)

Differences in relatives' and patients' illness perceptions in functional neurological symptom disorders compared with neurological diseases.
von: Whitehead, K, et al.
Veröffentlicht: (2015)

Rheology of growing axons
von: Oliveri, H, et al.
Veröffentlicht: (2022)

Autism : a neurological disorder of early brain development /
von: Tuchman, Roberto, et al.
Veröffentlicht: (2006)

Glycerophospholipids in the brain : phospholipases A2 in neurological disorders /
von: 180221 Farooqui, Akhlaq A., et al.
Veröffentlicht: (2007)

Evidence for a role for apoptosis in central pontine myelinolysis.
von: DeLuca, G, et al.
Veröffentlicht: (2002)